WCM26: Blister Breakthroughs: Emerging Targeted Therapies for Bullous Pemphigoid
Released on
February 13, 2026
WCM26: Blister Breakthroughs: Emerging Targeted Therapies for Bullous Pemphigoid
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.